EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Commutability assessment of new standard reference materials (SRMs) for determining serum total 25-hydroxyvitamin D using ligand binding and liquid chromatography–tandem mass spectrometry (LC–MS/MS) assays

Stephen A Wise, Étienne Cavalier, Pierre Lukas, Stéphanie Peeters, Caroline Le Goff, Laura E Briggs, Emma L Williams, Ekaterina Mineva, Christine M Pfeiffer, Hubert Vesper, Christian Popp, Christian Beckert und 34 weitere

Analytical and Bioanalytical Chemistry · 2025

DOI: 10.1007/s00216-024-05699-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical and Bioanalytical Chemistry, 2025. Verfasst von Stephen A Wise und 45 weiteren Autor:innen. Beteiligte Einrichtung: ICF Contractor in Support of National Institutes of Health (NIH), Office of Dietary Supplements (ODS), Bethesda, MD, 20817, USA. Stephen.wise@nih.gov. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Vitamin D. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Commutability is where the measurement response for a reference material (RM) is the same as for an individual patient sample with the same concentration of analyte measured using two or more measurement systems. Assessment of commutability is essential when the RM is used in a calibration hierarchy or to ensure that clinical measurements are comparable across different measurement procedures and at different times. The commutability of three new Standard Reference Materials ® (SRMs) for determining serum total 25-hydroxyvitamin D [25(OH)D], defined as the sum of 25-hydroxyvitamin D 2 [25(OH)D 2 ] and 25-hydroxyvitamin D 3 [25(OH)D 3 ], was assessed through an interlaboratory study. The following SRMs were assessed: (1) SRM 2969 Vitamin D Metabolites in Frozen Human Serum (Total 25-Hydroxyvitamin D Low Level), (2) SRM 2970 Vitamin D Metabolites in Frozen Human Serum (25-Hydroxyvitamin D 2 High Level), and (3) SRM 1949 Frozen Human Prenatal Serum. These SRMs represent three clinically relevant situations including (1) low levels of total 25(OH)D, (2) high level of 25(OH)D 2 , and (3) 25(OH)D levels in nonpregnant women and women during each of the three trimesters of pregnancy with changing concentrations of vitamin D-binding protein (VDBP). Twelve laboratories using 17 different ligand binding assays and eight laboratories using nine commercial and custom liquid chromatography–tandem mass spectrometry (LC–MS/MS) assays provided results in this study. Commutability of the SRMs with patient samples was assessed using the Clinical and Laboratory Standards Institute (CLSI) approach based on 95% prediction intervals or a pre-set commutability criterion and the recently introduced International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) approach based on differences in bias for the clinical and reference material samples using a commutability criterion of 8.8%. All three SRMs were deemed as commutable with all LC–MS/MS assays using both CLSI and IFCC approaches. SRM 2969 and SRM 2970 were deemed noncommutable for three and seven different ligand binding assays, respectively, when using the IFCC approach. Except for two assays, one or more of the three pregnancy levels of SRM 1949 were deemed noncommutable or inconclusive using different ligand binding assays and the commutability criterion of 8.8%. Overall, a noncommutable assessment for ligand binding assays is determined for these SRMs primarily due to a lack of assay selectivity related to 25(OH)D 2 or an increasing VDBP in pregnancy trimester materials rather than the quality of the SRMs. With results from 17 different ligand binding and nine LC–MS/MS assays, this study provides valuable knowledge for clinical laboratories to inform SRM selection when assessing 25(OH)D status in patient populations, particularly in subpopulations with low levels of 25(OH)D, high levels of 25(OH)D 2 , women only, or women who are pregnant. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryVitamin DHumansChromatography, LiquidReference StandardsFemaleLigandsPregnancyCalcifediolLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

25-Hydroxyvitamin D225-Hydroxyvitamin D3ImmunoassayReference measurement procedure (RMP)Vitamin DVitamin D-binding protein (VDBP)

Substanzen

Vitamin D25-hydroxyvitamin DLigandsCalcifediol

Autor:innen und Institutionen

  • ICF Contractor in Support of National Institutes of Health (NIH), Office of Dietary Supplements (ODS), Bethesda, MD, 20817, USA. Stephen.wise@nih.gov.
  • University of Liège, Clinical Chemistry, CHU de Liège, Liège, BE, 4000, Belgium.
  • Imperial College Healthcare NHS Trust, London, W6 8RF, UK.
  • Centers for Disease Control and Prevention (CDC), Nutritional Biomarkers Branch, Atlanta, GA, 30341, USA.
  • Abbott Laboratories, ADD Wiesbaden Abbott GmbH, 65205, Wiesbaden, Germany.
  • Affimedix Inc., Hayward, CA, 94545, USA.

Förderung

  • Intramural NIH HHS
  • National Institutes of Health

Zitieren

APA

Wise, S. A., Cavalier, É., Lukas, P., Peeters, S., Le Goff, C., Briggs, L. E., Williams, E. L., Mineva, E., Pfeiffer, C. M., Vesper, H., Popp, C., Beckert, C., Schultess, J., Wang, K., Tourneur, C., Pease, C., Osterritter, D., Fischer, R., Saida, B., …, & Camara, J. E. (2025). Commutability assessment of new standard reference materials (SRMs) for determining serum total 25-hydroxyvitamin D using ligand binding and liquid chromatography–tandem mass spectrometry (LC–MS/MS) assays. Analytical and Bioanalytical Chemistry. https://doi.org/10.1007/s00216-024-05699-7

Vancouver

Wise SA, Cavalier É, Lukas P, Peeters S, Le Goff C, Briggs LE, et al. Commutability assessment of new standard reference materials (SRMs) for determining serum total 25-hydroxyvitamin D using ligand binding and liquid chromatography–tandem mass spectrometry (LC–MS/MS) assays. Analytical and Bioanalytical Chemistry. 2025. doi:10.1007/s00216-024-05699-7

BibTeX
@article{Wise2025,
  author = {Wise, Stephen A and Cavalier, Étienne and Lukas, Pierre and Peeters, Stéphanie and Le Goff, Caroline and Briggs, Laura E and Williams, Emma L and Mineva, Ekaterina and Pfeiffer, Christine M and Vesper, Hubert and Popp, Christian and Beckert, Christian and Schultess, Jan and Wang, Kevin and Tourneur, Carole and Pease, Camille and Osterritter, Dominik and Fischer, Ralf and Saida, Ben and Dou, Chao and Kojima, Satoshi and Weiler, Hope A and Bielecki, Agnieszka and Pham, Heather and Bennett, Alexandra and You, Shawn and Ghoshal, Amit K and Wei, Bin and Vogl, Christian and Freeman, James and Parker, Neil and Pagliaro, Samantha and Cheek, Jennifer and Li, Jie and Tsukamoto, Hisao and Galvin, Karen and Cashman, Kevin D and Liao, Hsuan-Chieh and Hoofnagle, Andrew N and Budd, Jeffery R and Kuszak, Adam J and Boggs, Ashley S P and Burdette, Carolyn Q and Hahm, Grace and Nalin, Federica and Camara, Johanna E},
  title = {Commutability assessment of new standard reference materials (SRMs) for determining serum total 25-hydroxyvitamin D using ligand binding and liquid chromatography–tandem mass spectrometry (LC–MS/MS) assays},
  journal = {Analytical and Bioanalytical Chemistry},
  year = {2025},
  doi = {10.1007/s00216-024-05699-7}
}
Kostenlos starten →